outside front cover
(Source: Seminars in Oncology)
Source: Seminars in Oncology - May 31, 2016 Category: Cancer & Oncology Source Type: research
Masthead
(Source: Seminars in Oncology)
Source: Seminars in Oncology - May 31, 2016 Category: Cancer & Oncology Source Type: research
Editorial Board
(Source: Seminars in Oncology)
Source: Seminars in Oncology - May 31, 2016 Category: Cancer & Oncology Source Type: research
Table of Contents
(Source: Seminars in Oncology)
Source: Seminars in Oncology - May 31, 2016 Category: Cancer & Oncology Source Type: research
ASCO Plenary Sessions: impact, legacy, future
The ASCO annual meeting draws a large crowd of physicians, cancer researchers, policy makers, and industry representatives. The crown jewel of the annual events is the Plenary session where impactful, influential and visible abstracts are selected for the largest audience. Plenary topics are frequently paired with concurrent New England Journal or Lancet publications. Here, we review 9 years of ASCO plenary sessions. Several themes emerge. First, many of the topics selected have indeed been practice changing, such as the use of ALK inhibitors for ALK rearranged NSCLC, or checkpoint inhibitors in metastatic melanoma.Â...
Source: Seminars in Oncology - May 11, 2016 Category: Cancer & Oncology Authors: Andrae Vandross, Vinay Prasad, Sham Mailankody Source Type: research
outside front cover
(Source: Seminars in Oncology)
Source: Seminars in Oncology - May 11, 2016 Category: Cancer & Oncology Source Type: research
Masthead
(Source: Seminars in Oncology)
Source: Seminars in Oncology - May 11, 2016 Category: Cancer & Oncology Source Type: research
Editorial Board
(Source: Seminars in Oncology)
Source: Seminars in Oncology - May 11, 2016 Category: Cancer & Oncology Source Type: research
Table of Contents
(Source: Seminars in Oncology)
Source: Seminars in Oncology - May 11, 2016 Category: Cancer & Oncology Source Type: research
Cutaneous manifestations associated with malignancy of the head and neck
Most cutaneous malignancies of the head and neck (HN) are non-melanoma skin cancers, predominantly basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs). Less common entities include Merkel cell carcinoma (MCC), sebaceous carcinoma (SC), and angiosarcoma. Treatment is based on histology subtype, stage, and extent of involvement. Surgery is the primary means of treatment and includes wide local excision, Mohs micrographic surgery, sentinel lymph node biopsy, and cervical lymphadenectomy. (Source: Seminars in Oncology)
Source: Seminars in Oncology - April 6, 2016 Category: Cancer & Oncology Authors: Patrick Lorimer, Zvonimir Milas Source Type: research
outside front cover
(Source: Seminars in Oncology)
Source: Seminars in Oncology - March 31, 2016 Category: Cancer & Oncology Source Type: research
Masthead
(Source: Seminars in Oncology)
Source: Seminars in Oncology - March 31, 2016 Category: Cancer & Oncology Source Type: research
Editorial Board
(Source: Seminars in Oncology)
Source: Seminars in Oncology - March 31, 2016 Category: Cancer & Oncology Source Type: research
Table of Contents
(Source: Seminars in Oncology)
Source: Seminars in Oncology - March 31, 2016 Category: Cancer & Oncology Source Type: research
